home / stock / twst / twst quote
Last: | $47.32 |
---|---|
Change Percent: | 0.22% |
Open: | $48.82 |
Close: | $47.32 |
High: | $48.84 |
Low: | $46.04 |
Volume: | 923,575 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$47.32 | $48.82 | $47.32 | $48.84 | $46.04 | 923,575 | 07-02-2024 |
$48.93 | $48.29 | $48.93 | $51.25 | $48.29 | 1,126,362 | 07-01-2024 |
$49.28 | $48.29 | $49.28 | $49.6 | $47.17 | 3,708,942 | 06-28-2024 |
$47.48 | $46.49 | $47.48 | $48.32 | $45.61 | 725,665 | 06-27-2024 |
$46.47 | $47.51 | $46.47 | $48.22 | $46.2 | 910,922 | 06-26-2024 |
$47.83 | $49.12 | $47.83 | $49.85 | $47.5941 | 616,152 | 06-25-2024 |
$49.26 | $50.97 | $49.26 | $52.6865 | $49.115 | 751,243 | 06-24-2024 |
$50.97 | $48.96 | $50.97 | $50.99 | $48.18 | 2,570,597 | 06-21-2024 |
$48.74 | $49.75 | $48.74 | $50.8 | $48.51 | 887,919 | 06-20-2024 |
$50.56 | $48.89 | $50.56 | $51.22 | $48.12 | 837,970 | 06-19-2024 |
$50.56 | $48.89 | $50.56 | $51.22 | $48.12 | 837,970 | 06-18-2024 |
$49 | $49.52 | $49 | $51.07 | $48.11 | 1,302,522 | 06-17-2024 |
$49.84 | $50.88 | $49.84 | $51.52 | $49.19 | 968,249 | 06-14-2024 |
$52.03 | $52.98 | $52.03 | $54.64 | $51.915 | 1,033,699 | 06-13-2024 |
$52.44 | $53.1 | $52.44 | $55.26 | $49.14 | 1,680,137 | 06-12-2024 |
$51.59 | $49.1 | $51.59 | $52.29 | $48.58 | 967,025 | 06-11-2024 |
$50.01 | $49.45 | $50.01 | $50.54 | $48.17 | 969,826 | 06-10-2024 |
$50.46 | $51.84 | $50.46 | $52 | $50.25 | 1,039,920 | 06-07-2024 |
$53 | $52.19 | $53 | $53.8 | $50.11 | 1,481,856 | 06-06-2024 |
$52.83 | $47.87 | $52.83 | $54.1333 | $47.75 | 2,463,609 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
2024-06-28 07:15:04 ET Barclays analyst issues OVERWEIGHT recommendation for TWST on June 28, 2024 05:29AM ET. The previous analyst recommendation was Overweight. TWST was trading at $47.48 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
TB206-001 shown to be a high-affinity, cross-reactive humanized antibody antagonist of A 2A R with in vivo tumor suppressing activity TB206-001 available for out-licensing Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering...
Twist Bioscience Corporation (NASDAQ: TWST) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 11.58% on the day to $52.42. Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-bas...